Nathalie Adda - Net Worth and Insider Trading
Nathalie Adda Net Worth
The estimated net worth of Nathalie Adda is at least $372,908 dollars as of 2024-11-13. Nathalie Adda is the Sr. VP & Chief Medical Officer of Enanta Pharmaceuticals Inc and owns about 34,982 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $372,908. Details can be seen in Nathalie Adda's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nathalie Adda has not made any transactions after 2022-04-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nathalie Adda
Nathalie Adda Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nathalie Adda owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .
Click here to see the complete history of Nathalie Adda’s form 4 insider trades.
Insider Ownership Summary of Nathalie Adda
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2022-04-04 | Sr. VP & Chief Medical Officer |
Nathalie Adda Latest Holdings Summary
Nathalie Adda currently owns a total of 1 stock. Nathalie Adda owns 34,982 shares of Enanta Pharmaceuticals Inc (ENTA) as of April 4, 2022, with a value of $372,908.
Latest Holdings of Nathalie Adda
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2022-04-04 | 34,982 | 10.66 | 372,908 |
Holding Weightings of Nathalie Adda
Nathalie Adda Form 4 Trading Tracker
According to the SEC Form 4 filings, Nathalie Adda has made a total of 6 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 83,344 shares on April 4, 2022, which brought Nathalie Adda around $6 Million.
Insider Trading History of Nathalie Adda
- 1
Nathalie Adda Trading Performance
Nathalie Adda Ownership Network
Ownership Network List of Nathalie Adda
Ownership Network Relation of Nathalie Adda
Nathalie Adda Owned Company Details
What does Enanta Pharmaceuticals Inc do?
Who are the key executives at Enanta Pharmaceuticals Inc?
Nathalie Adda is the Sr. VP & Chief Medical Officer of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & New Product Dev. Tara Lynn Kieffer , and Sr. VP & Business Dev. Brendan Luu .
Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary
Over the past 18 months, Nathalie Adda made no insider transaction in Enanta Pharmaceuticals Inc (ENTA). Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 12,479 shares made by Scott T. Rottinghaus , a net sale of 9,391 shares made by Tara Lynn Kieffer , and a net sale of 15,295 shares made by Terry Vance .
In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 53,756 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,756 shares.
Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enanta Pharmaceuticals Inc Insider Transactions
Nathalie Adda Mailing Address
Above is the net worth, insider trading, and ownership report for Nathalie Adda. You might contact Nathalie Adda via mailing address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
